NDC 69880-120
Mycapssa 20 mg capsule, delayed release
On the label: Amryt Pharmaceuticals Designated Activity Company.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Assia Chemical Industries Ltd. - Teva Tech Site | Be'er Sheva, Israel | Makes the active ingredient | Problems found, fixed voluntarilySep 12, 2019 · 3 inspections |
| Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services | Bedford, NH, United States | Makes it | Problems found, fixed voluntarilyJun 10, 2026 · 8 inspections |
| MW Encap Limited | Livingston, United Kingdom | Makes it and tests it | Problems found, fixed voluntarilyJun 24, 2021 · 5 inspections |
| Novetide Ltd. | Netanya, Israel | Makes the active ingredient | No problems foundNov 14, 2019 · 3 inspections |
| Almac Pharma Services Limited | Craigavon, United Kingdom | Packages it and labels it | Problems found, fixed voluntarilyNov 28, 2025 · 8 inspections |
Product details
- Generic drug
- Octreotide: every company that makes it
- Form
- capsule, delayed release, oral
- Strength
- 20 mg
- Approval
- NDA NDA208232
- On the market since
- Jul 6, 2020
- Package NDCs
69880-120-28- Official label
- DailyMed (National Library of Medicine), updated Jul 24, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?